Biocon Buys Stake in German Pharma Distributor

Biotechnology company Biocon (Bangalore, India) says it has reached an agreement to acquire a 70% stake in pharmaceutical distributor AxiCorp (Friedrichsdorf, Germany) for €30 million. Biocon says the acquisition will help it market products—including generics, biosimilars, biologics, and innovative pharmaceutical products—in Europe. Mazumdar-Shaw: Closer to Europe. Biocon specializes in biopharmaceuticals, custom and clinical research, as well as enzymes. AxiCorp markets and distributes generics and parallel imported pharmaceuticals in...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers